保护对由辅助剂配方01的辅助子单位疫苗引起的实验性加密球菌病的保护
Ruiying Wang1, Lorena V N Oliveira1, Maureen M Hester1
1Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.
PLoS pathogens
|July 8, 2024
概括
结合Cryptococcus neoformans抗原与辅助剂CAF01的新型亚单元疫苗证明了对小鼠的加密球菌病的显著保护. 这些有希望的临床前结果为人类疫苗试验铺平了道路.
科学领域:
- 菌类学 菌类学是指菌类学.
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 一种真菌感染的加密球菌病每年造成超过10万人的死亡,而没有获得许可的疫苗.
- 亚单元疫苗提供了一种潜在的预防密码球菌病的策略,但需要有效的辅助剂来引起强大的免疫反应.
研究的目的:
- 评估针对加密球菌病的新型亚单元疫苗的疗效和免疫性.
- 评估辅助剂配方01 (CAF01) 在增强疫苗诱导的免疫反应中的作用.
主要方法:
- 小鼠接受了单,双价或四价重组Cryptococcus neoformans蛋白质抗原的皮下接种,并添加了CAF01.01作为辅助剂.
- 疫苗的有效性通过C. neoformans的肺部挑战来评估.
- 免疫反应,包括T细胞种群 (CD4+和CD8+) 和细胞因子产生 (IFNγ,TNFα,IL-17),在肺组织,和血液中进行了分析.
主要成果:
- 单抗原疫苗提供了部分保护,而双价和四价配方在小鼠中实现了高达100%的保护.
- 接种疫苗的小鼠在肺部呈现出白细胞的增加,包括产生IFNγ,TNFα和IL-17的多功能CD4+T细胞.
- 在多种组织中观察到显著且持久的IFNγ反应,与真菌控制直接相关.
结论:
- 用CAF01配制的多价位子单元疫苗有效地保护小鼠免受实验性加密球菌病的感染.
- 辅助剂CAF01促进Th1和Th17免疫反应,这对菌控制至关重要.
- 这些发现支持这些加密球菌疫苗进入人类临床试验的进步.
更多相关视频
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
10.6K
06:57Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
2.1K
相关概念视频
01:51Vaccinations
Overview
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...